Cargando…
Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial
OBJECTIVE: T-cell activation independently predicts mortality, poor immune recovery and non-AIDS illnesses during combination antiretroviral therapy (cART). Atorvastatin showed anti-immune activation effects among HIV-infected cART-naïve individuals. We investigated whether adjunct atorvastatin ther...
Autores principales: | Nakanjako, Damalie, Ssinabulya, Isaac, Nabatanzi, Rose, Bayigga, Lois, Kiragga, Agnes, Joloba, Moses, Kaleebu, Pontiano, Kambugu, Andrew D., Kamya, Moses R., Sekaly, Rafick, Elliott, Alison, Mayanja-Kizza, Harriet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529480/ https://www.ncbi.nlm.nih.gov/pubmed/25441397 http://dx.doi.org/10.1111/tmi.12442 |
Ejemplares similares
-
High CD56(++)CD16(-) natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort
por: Bayigga, Lois, et al.
Publicado: (2014) -
Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort
por: Nakanjako, Damalie, et al.
Publicado: (2013) -
High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort
por: Nakanjako, Damalie, et al.
Publicado: (2011) -
Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohort
por: Nabatanzi, Rose, et al.
Publicado: (2019) -
Monocyte Dysfunction, Activation, and Inflammation After Long-Term Antiretroviral Therapy in an African Cohort
por: Nabatanzi, Rose, et al.
Publicado: (2019)